title: Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.
abstract: Immunoglobulin genes are generated somatically through specialized mechanisms resulting in a vast repertoire of antigen-binding sites. Despite the stochastic nature of these processes, the V-genes that encode most of the antigen-combining site are under positive evolutionary selection, raising the possibility that V-genes have been selected to encode key structural features of binding sites of protective antibodies against certain pathogens. Human, neutralizing antibodies to human cytomegalovirus that bind the AD-2S1 epitope on its gB envelope protein repeatedly use a pair of well-conserved, germline V-genes IGHV3-30 and IGKV3-11. Here, we present crystallographic, kinetic and thermodynamic analyses of the binding site of such an antibody and that of its primary immunoglobulin ancestor. These show that these germline V-genes encode key side chain contacts with the viral antigen and thereby dictate key structural features of the hypermutated, high-affinity neutralizing antibody. V-genes may thus encode an innate, protective immunological memory that targets vulnerable, invariant sites on multiple pathogens.
authors.affiliation: The Biomedical Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Christy A
authors.initials: CA
authors.lastname: Thomson
authors.forename: Steve
authors.initials: S
authors.lastname: Bryson
authors.forename: Gary R
authors.initials: GR
authors.lastname: McLean
authors.forename: A Louise
authors.initials: AL
authors.lastname: Creagh
authors.forename: Emil F
authors.initials: EF
authors.lastname: Pai
authors.forename: John W
authors.initials: JW
authors.lastname: Schrader
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000235:genetics / Q000276:immunology*; D001666:Binding Sites, Antibody; D003587:Cytomegalovirus / Q000276:immunology*; D005803:Genes, Immunoglobulin; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000235:genetics* / Q000378:metabolism; D008958:Models, Molecular; D008969:Molecular Sequence Data; D017434:Protein Structure, Tertiary; D013816:Thermodynamics
chemical_list: D000911:Antibodies, Monoclonal; D007135:Immunoglobulin Variable Region
references.citation: Immunol Rev. 1999 Oct;171:89-104
references.pmid: 10582166
references.citation: Immunity. 2006 Apr;24(4):429-38
references.pmid: 16618601
references.citation: J Mol Biol. 2005 Apr 15;347(5):965-78
references.pmid: 15784256
references.citation: J Immunol. 1999 Jan 1;162(1):224-37
references.pmid: 9886390
references.citation: J Gen Virol. 1992 Oct;73 ( Pt 10):2705-7
references.pmid: 1328482
references.citation: Infect Immun. 2002 Aug;70(8):4083-91
references.pmid: 12117915
references.citation: Immunol Rev. 1988 Oct;105:85-96
references.pmid: 3058581
references.citation: Trends Immunol. 2004 Apr;25(4):174-9
references.pmid: 15039043
references.citation: Proteins. 2001 Nov 15;45(3):199-206
references.pmid: 11599023
references.citation: Clin Infect Dis. 1992 Jan;14(1):251-62
references.pmid: 1571441
references.citation: Nat Struct Biol. 2003 Jun;10(6):482-8
references.pmid: 12740607
references.citation: Semin Immunol. 2004 Aug;16(4):239-43
references.pmid: 15522622
references.citation: Immunity. 1998 Jun;8(6):751-9
references.pmid: 9655489
references.citation: J Exp Med. 1996 Nov 1;184(5):1685-97
references.pmid: 8920858
references.citation: Scand J Immunol. 1993 Oct;38(4):327-34
references.pmid: 7692591
references.citation: Eur J Immunol. 2004 May;34(5):1423-32
references.pmid: 15114676
references.citation: Science. 2003 Feb 28;299(5611):1362-7
references.pmid: 12610298
references.citation: In Silico Biol. 2005;5(1):45-60
references.pmid: 15972004
references.citation: Science. 1997 Jun 13;276(5319):1665-9
references.pmid: 9180069
references.citation: Science. 1994 Feb 11;263(5148):777-84
references.pmid: 8303294
references.citation: J Gen Virol. 1990 Oct;71 ( Pt 10):2443-50
references.pmid: 1700066
references.citation: J Immunol. 1998 Oct 1;161(7):3776-80
references.pmid: 9759904
references.citation: Nat Immunol. 2002 May;3(5):457-62
references.pmid: 11938351
references.citation: Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
references.pmid: 9757107
references.citation: J Immunol. 2005 Apr 15;174(8):4768-78
references.pmid: 15814702
references.citation: J Endotoxin Res. 2004;10(6):413-8
references.pmid: 15588424
references.citation: Infect Immun. 1999 Mar;67(3):1172-9
references.pmid: 10024557
references.citation: J Virol. 2000 Nov;74(22):10401-6
references.pmid: 11044084
references.citation: Science. 2006 Jun 16;312(5780):1672-6
references.pmid: 16778060
references.citation: Mol Biol Evol. 1989 Sep;6(5):447-59
references.pmid: 2796726
references.citation: Chem Rev. 1997 Aug 5;97(5):1233-1250
references.pmid: 11851449
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references.pmid: 15572765
references.citation: Pediatr Infect Dis J. 1992 Feb;11(2):93-9
references.pmid: 1311066
references.citation: Mol Immunol. 2006 May;43(12):2012-22
references.pmid: 16423397
references.citation: J Immunol. 2002 Jul 15;169(2):888-97
references.pmid: 12097393
references.citation: Int Rev Immunol. 1992;9(1):25-43
references.pmid: 1484268
references.citation: N Engl J Med. 2005 Sep 29;353(13):1350-62
references.pmid: 16192480
references.citation: J Mol Biol. 1996 Mar 15;256(5):813-17
references.pmid: 8601832
references.citation: Immunity. 2000 Nov;13(5):611-20
references.pmid: 11114374
references.citation: Nature. 1984 Oct 25-31;311(5988):752-5
references.pmid: 6092963
references.citation: J Gen Virol. 2002 Aug;83(Pt 8):2001-2005
references.pmid: 12124464
references.citation: J Virol. 1993 Feb;67(2):703-10
references.pmid: 7678304
references.citation: N Engl J Med. 2005 Sep 29;353(13):1402-4
references.pmid: 16192488